Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

Integrating MOUD in Nonmedical Community Settings (Better Together)

A legfontosabb adatok

Ki végzi
Howard University
Hol
Baltimore, Chicago, Miami és Washington D.C. (Egyesült Államok)Mind a 4 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
400 fő, tervezett
Kezdés
2026. ápr. 15.
Várható befejezés
2029. jún. 1.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • HC-MOUD Only
  • BT-MOUD with Buprenorphine
A regiszteradat frissítve
2026. október 13.

Ki vehet részt

Életkor
16 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 9 feltétel megnézéseKevesebb

Ki vehet részt

  • Be 16 years of age or older
  • Has been newly prescribed MOUD with buprenorphine by a hub clinic provider no more than 90 days before the day of randomization or on the day of randomization. [Note that the "start" of a "current, new treatment episode" of MOUD with buprenorphine is defined as the date MOUD with buprenorphine was prescribed by a hub clinic provider.]
  • Is willing and able to provide written informed consent
  • Is willing and able to provide reliable locator information to facilitate contacting the participant for research follow-up assessments
  • Speaks English well enough to be able to comprehend the study procedures and complete the assessments

Ki nem vehet részt

  • In the 30 days prior to receiving the prescription for MOUD with buprenorphine from the hub clinic provider, has been covered by MOUD (oral, sublingual, injection) as an outpatient for more than 10 consecutive days. [Note that receipt of MOUD in a hospital, residential treatment, or carceral setting would not trigger exclusion.]
  • Has been previously enrolled in CTN-0144 or CTN-0088 or is currently enrolled in another clinical trial for treatment of OUD
  • Plans to move out of the area or anticipate not being able to remain in the study for 6 months
  • Is currently in jail, prison, or other overnight facility as required by a court of law or have pending legal action that could prevent participation in study activities

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • University of MarylandBaltimore, Egyesült ÁllamokContact: Eric Weintraub, MDRésztvevőt keres
  • University of Illinois ChicagoChicago, Egyesült ÁllamokContact: Niranjan Karnik, MD, PhDRésztvevőt keres
  • University of MiamiMiami, Egyesült ÁllamokContact: Viviana Horigian, MD, MHARésztvevőt keres
  • Howard UniversityWashington D.C., Egyesült ÁllamokContact: Richard S Schottenfeld, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

A multisite effectiveness-implementation study will be conducted in four sites to evaluate interventions to improve engagement and retention in MOUD with buprenorphine treatment persons with Opioid Use Disorder (OUD) in urban neighborhoods with high overdose rates. The investigators hypothesize that treatment with the Better Together Integrated Collaborative Community MOUD care model (BT-MOUD) will result in better retention in treatment than standard-of-care MOUD with buprenorphine provided in the hub buprenorphine clinic only (HC-MOUD Only) through 24 weeks following randomization. BT-MOUD provides MOUD with buprenorphine in nonmedical community-based settings via telemedicine from a hub buprenorphine clinic combined with Recovery Guiding, a manual guided coaching developed for this approach, provided onsite in the community organization.

A vizsgálat 2 csoportja

  • Hub Clinic MOUD with buprenorphine only (HC-MOUD Only)Már használt kezelés, összehasonlításként

    Participants will receive MOUD with buprenorphine prescribed by providers based at participating hub clinics. MOUD treatment with buprenorphine will follow standard guidelines for induction and maintenance using a sublingual buprenorphine formulation. Hub clinic buprenorphine providers and participants may shift to long acting injection buprenorphine formulations after initial induction with sublingual buprenorphine. If telemedicine prescribing of MOUD with buprenorphine is part of the usual standard of care at the clinic, participants assigned to HC-MOUD Only may be prescribed buprenorphine via telemedicine, following the clinic's usual guidelines. Participants may not receive telemedicine services at the community spokes or Recovery Guiding, which are available only to participants assigned to BTMOUD. All study participants, however, may have access to any services that are routinely provided as part of the MOUD with buprenorphine treatment-as-usual care in the hub clinic.

    Kezelés: HC-MOUD Only

  • Recovery Guiding / Better Together Medications for Opioid Use Disorder (BT-MOUD) proceduresA vizsgált kezelés

    Better Together Medications for Opioid Use Disorder (BT-MOUD) includes HC-MOUD plus access to telemedicine provision of MOUD with buprenorphine at a nonmedical community organization spoke, plus manual-guided Recovery Guiding provided onsite at the spoke, and plus any other services available at the community organization spoke. Recovery Guiding is a manualized, highly structured, stepwise intervention that uses educational and behavioral tools to provide pragmatic guidance for patients beginning buprenorphine treatment and to address the key recovery misconceptions and dysfunctional behaviors that frequently interfere with recovery efforts of patients initiating medication for opioid use disorder (MOUD) treatment.

    Kezelés: BT-MOUD with Buprenorphine

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. október 13.